Idexx Laboratories (IDXX) Short-term Investments (2015 - 2017)

Idexx Laboratories has reported Short-term Investments for 3 years, with the latest figure at $284.3 million in Q4 2017.

• On a quarterly basis, Short-term Investments rose 19.96% year-over-year to $284.3 million in Q4 2017; TTM through Dec 2017 was $284.3 million, a 19.96% increase from a year earlier, with the FY2017 full-year figure at $284.3 million, up 19.96% from the prior year.
• Short-term Investments was $284.3 million for Q4 2017 at Idexx Laboratories, up from $269.8 million in the prior quarter.
• The five-year high for Short-term Investments was $284.3 million in Q4 2017, with the low at $139.2 million in Q1 2015.
• Average Short-term Investments over 3 years is $219.7 million, with a median of $223.3 million recorded in 2016.
• The sharpest annual moves came in 2016 and 2017: Short-term Investments soared 56.32% in 2016, then dropped 23.37% in 2017.
• Over 3 years, Short-term Investments stood at $213.6 million in 2015, then gained by 10.94% to $236.9 million in 2016, then advanced by 19.96% to $284.3 million in 2017.
• The last three Short-term Investments figures came in at $284.3 million (Q4 2017), $269.8 million (Q3 2017), and $175.5 million (Q2 2017), per Business Quant data.